Home
>
National Drug Code (NDC)
>
LUXIQ
LUXIQ - 63032-021-00 - (betamethasone valerate)
Drug Information of LUXIQ
| Product NDC: | 63032-021 |
| Proprietary Name: | LUXIQ |
| Non Proprietary Name: | betamethasone valerate |
| Active Ingredient(s): | 1.2 mg/g & nbsp; betamethasone valerate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | AEROSOL, FOAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LUXIQ
| Product NDC: | 63032-021 |
| Labeler Name: | Stiefel Laboratories Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020934 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20091016 |
Package Information of LUXIQ
| Package NDC: | 63032-021-00 |
| Package Description: | 100 g in 1 CAN (63032-021-00) |
NDC Information of LUXIQ
| NDC Code | 63032-021-00 |
| Proprietary Name | LUXIQ |
| Package Description | 100 g in 1 CAN (63032-021-00) |
| Product NDC | 63032-021 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | betamethasone valerate |
| Dosage Form Name | AEROSOL, FOAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20091016 |
| Marketing Category Name | NDA |
| Labeler Name | Stiefel Laboratories Inc |
| Substance Name | BETAMETHASONE VALERATE |
| Strength Number | 1.2 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
